Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 356487, 10 pages
http://dx.doi.org/10.1155/2012/356487
Research Article

Amelioration of Glucolipotoxicity-Induced Endoplasmic Reticulum Stress by a “Chemical Chaperone” in Human THP-1 Monocytes

1Department of Cell and Molecular Biology, Madras Diabetes Research Foundation and Dr. Mohans’ Diabetes Specialities Centre, Chennai 600086, India
2Centre for Biotechnology, Anna University, Chennai 600025, India

Received 17 December 2011; Accepted 13 February 2012

Academic Editor: Rangasamy Sampathkumar

Copyright © 2012 Raji Lenin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, and N. Day, “Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk,” Annals of Internal Medicine, vol. 141, no. 6, pp. 413–420, 2004. View at Google Scholar · View at Scopus
  2. C. J. Binder, M. K. Chang, P. X. Shaw et al., “Innate and acquired immunity in atherogenesis,” Nature Medicine, vol. 8, no. 11, pp. 1218–1226, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Ron and P. Walter, “Signal integration in the endoplasmic reticulum unfolded protein response,” Nature Reviews Molecular Cell Biology, vol. 8, no. 7, pp. 519–529, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. D. L. Eizirik, A. K. Cardozo, and M. Cnop, “The role for endoplasmic reticulum stress in diabetes mellitus,” Endocrine Reviews, vol. 29, no. 1, pp. 42–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. V. Poitout and R. P. Robertson, “Glucolipotoxicity: fuel excess and β-cell dysfunction,” Endocrine Reviews, vol. 29, no. 3, pp. 351–366, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Bachar, Y. Ariav, M. Ketzinel-Gilad, E. Cerasi, N. Kaiser, and G. Leibowitz, “Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic β-cells via activation of mTORC1,” PLoS One, vol. 4, no. 3, Article ID e4954, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Shimoda, Y. Kanda, S. Hamamoto et al., “The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes,” Diabetologia, vol. 54, no. 5, pp. 1098–1108, 2011. View at Publisher · View at Google Scholar
  8. Y. Nakatani, H. Kaneto, D. Kawamori et al., “Involvement of endoplasmic reticulum stress in insulin resistance and diabetes,” Journal of Biological Chemistry, vol. 280, no. 1, pp. 847–851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Marchetti, M. Bugliani, R. Lupi et al., “The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients,” Diabetologia, vol. 50, no. 12, pp. 2486–2494, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. D. R. Laybutt, A. M. Preston, M. C. Åkerfeldt et al., “Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes,” Diabetologia, vol. 50, no. 4, pp. 752–763, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Chen, P. Jin, H.-H. He, Y.-H. Xie, X.-Y. Xie, and Z.-H. Mo, “Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c,” Journal of Biomedical Science, vol. 18, no. 1, article 57, 2011. View at Publisher · View at Google Scholar
  12. J. Llodrá, V. Angeli, J. Liu, E. Trogan, E. A. Fisher, and G. J. Rendolph, “Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 32, pp. 11779–11784, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Thorp, G. Li, T. A. Seimon, G. Kuriakose, D. Ron, and I. Tabas, “Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe/ and Ldlr/ mice lacking CHOP,” Cell Metabolism, vol. 9, no. 5, pp. 474–481, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Balasubramanyam, A. A. Koteswari, R. S. Kumar, S. F. Monickaraj, J. U. Maheswari, and V. Mohan, “Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications,” Journal of Biosciences, vol. 28, no. 6, pp. 715–721, 2003. View at Google Scholar · View at Scopus
  15. M. Balasubramanyam, S. Aravind, K. Gokulakrishnan et al., “Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes,” Molecular and Cellular Biochemistry, vol. 351, no. 1-2, pp. 197–205, 2011. View at Publisher · View at Google Scholar
  16. A. Adaikalakoteswari, M. Rema, V. Mohan, and M. Balasubramanyam, “Oxidative DNA damage and augmentation of poly(ADP-ribose) polymerase/nuclear factor-kappa B signaling in patients with Type 2 diabetes and microangiopathy,” International Journal of Biochemistry and Cell Biology, vol. 39, no. 9, pp. 1673–1684, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Hiramatsu and S. Arimori, “Increased superoxide production by mononuclear cells of patients with hypertriglyceridemia and diabetes,” Diabetes, vol. 37, no. 6, pp. 832–837, 1988. View at Google Scholar · View at Scopus
  18. N. N. Orie, W. Zidek, and M. Tepel, “Increased intracellular generation of reactive oxygen species in mononuclear leukocytes from patients with diabetes mellitus type 2,” Experimental and Clinical Endocrinology and Diabetes, vol. 108, no. 3, pp. 175–180, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Sampathkumar, M. Balasubramanyam, C. Tara, M. Rema, and V. Mohan, “Association of hypoglutathionemia with reduced Na+/K+ ATPase activity in type 2 diabetes and microangiopathy,” Molecular and Cellular Biochemistry, vol. 282, no. 1-2, pp. 169–176, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Balasubramanyam, A. Adaikalakoteswari, R. Sampathkumar, and V. Mohan, “Oxidative stress in Asian Indians with Type 2 diabetes,” in Type 2 diabetes in South Asians: Epidemiology, Risk Factors and Prevention, pp. 164–172, Jaypee Brothers, Medical Publishers, New Delhi, India, 2006. View at Google Scholar
  21. A. Adaikalakoteswari, M. Balasubramanyam, M. Rema, and V. Mohan, “Differential gene expression of NADPH oxidase (p22phox) and hemoxygenase-1 in patients with Type 2 diabetes and microangiopathy,” Diabetic Medicine, vol. 23, no. 6, pp. 666–674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. J. D. Malhotra and R. J. Kaufman, “Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?” Antioxidants and Redox Signaling, vol. 9, no. 12, pp. 2277–2293, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Balasubramanyam, R. Lenin, and F. Monickaraj, “Endoplasmic reticulum stress in diabetes: new insights of clinical relevance,” Indian Journal of Clinical Biochemistry, vol. 25, no. 2, pp. 111–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Srinivasan, U. Tatu, V. Mohan, and M. Balasubramanyam, “Molecular convergence of hexosamine biosynthetic pathway and ER stress leading to insulin resistance in L6 skeletal muscle cells,” Molecular and Cellular Biochemistry, vol. 328, no. 1-2, pp. 217–224, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Feng, P. M. Yaol, Y. Li et al., “The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages,” Nature Cell Biology, vol. 5, no. 9, pp. 781–792, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. G. M. Salido, S. O. Sage, and J. A. Rosado, “TRPC channels and store-operated Ca2+ entry,” Biochimica et Biophysica Acta, vol. 1793, no. 2, pp. 223–230, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Balasubramanyam, R. A. Balaji, B. Subashini, and V. Mohan, “Evidence for mechanistic alterations of Ca2+ homeostasis in Type 2 diabetes mellitus,” International journal of experimental diabetes research, vol. 1, no. 4, pp. 275–287, 2001. View at Google Scholar · View at Scopus
  28. Z. Zhu, Z. Luo, S. Ma, and D. Liu, “TRP channels and their implications in metabolic diseases,” Pflugers Archiv European Journal of Physiology, vol. 461, no. 2, pp. 211–223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Yoshida, A. Monji, K. I. Tashiro, K. I. Nakamura, R. Inoue, and S. Kanba, “Depletion of intracellular Ca2+ store itself may be a major factor in thapsigargin-induced ER stress and apoptosis in PC12 cells,” Neurochemistry International, vol. 48, no. 8, pp. 696–702, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Orrenius, B. Zhivotovsky, and P. Nicotera, “Regulation of cell death: the calcium-apoptosis link,” Nature Reviews Molecular Cell Biology, vol. 4, no. 7, pp. 552–565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. B. A. Miller, “The role of TRP channels in oxidative stress-induced cell death,” Journal of Membrane Biology, vol. 209, no. 1, pp. 31–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Dietrich, M. Mederos Y Schnitzler, M. Gollasch et al., “Increased vascular smooth muscle contractility in TRPC6/ mice,” Molecular and Cellular Biology, vol. 25, no. 16, pp. 6980–6989, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Onohara, M. Nishida, R. Inoue et al., “TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy,” EMBO Journal, vol. 25, no. 22, pp. 5305–5316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Chen, F.-F. He, H. Wang et al., “Calcium entry via TRPC6 mediates albumin overload-induced endoplasmic reticulum stress and apoptosis in podocytes,” Cell Calcium, vol. 50, no. 6, pp. 523–529, 2011. View at Publisher · View at Google Scholar
  35. A. W. Y. Chung, K. Au Yeung, E. Chum, E. B. Okon, and C. van Breemen, “Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein,” European Journal of Pharmacology, vol. 613, no. 1–3, pp. 114–118, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Wuensch, F. Thilo, K. Krueger, A. Scholze, M. Ristow, and M. Tepel, “High glucose-induced oxidative stress increases transient receptor potential channel expression in human monocytes,” Diabetes, vol. 59, no. 4, pp. 844–849, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Komura, Y. Sakai, M. Honda, T. Takamura, K. Matsushima, and S. Kaneko, “CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes,” Diabetes, vol. 59, no. 3, pp. 634–643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Eisenberg-Lerner, S. Bialik, H. U. Simon, and A. Kimchi, “Life and death partners: apoptosis, autophagy and the cross-talk between them,” Cell Death and Differentiation, vol. 16, no. 7, pp. 966–975, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. C. D. Gonzalez, M. S. Lee, P. Marchetti et al., “The emerging role of autophagy in the pathophysiology of diabetes mellitus,” Autophagy, vol. 7, no. 1, pp. 2–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. N. A. Kaniuk, M. Kiraly, H. Bates, M. Vranic, A. Volchuk, and J. H. Brumell, “Ubiquitinated-protein aggregates form in pancreatic β-cells during diabetes-induced oxidative stress and are regulated by autophagy,” Diabetes, vol. 56, no. 4, pp. 930–939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. T. P. Carroll, C. M. Greene, C. A. O'Connor, A. M. Nolan, S. J. O'Neill, and N. G. McElvaney, “Evidence for unfolded protein response activation in monocytes from individuals with α-1 antitrypsin deficiency,” Journal of Immunology, vol. 184, no. 8, pp. 4538–4546, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. I. Tabas, “The role of endoplasmic reticulum stress in the progression of atherosclerosis,” Circulation Research, vol. 107, no. 7, pp. 839–850, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. U. Özcan, E. Yilmaz, L. Özcan et al., “Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes,” Science, vol. 313, no. 5790, pp. 1137–1140, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. S. E. Choi, Y. J. Lee, H. J. Jang et al., “A chemical chaperone 4-PBA ameliorates palmitate-induced inhibition of glucose-stimulated insulin secretion (GSIS),” Archives of Biochemistry and Biophysics, vol. 475, no. 2, pp. 109–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Basseri, Š. Lhoták, A. M. Sharma, and R. C. Austin, “The chemical chaperon 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response,” Journal of Lipid Research, vol. 50, no. 12, pp. 2486–2501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. F. E. Cohen and J. W. Kelly, “Therapeutic approaches to protein-misfolding diseases,” Nature, vol. 426, no. 6968, pp. 905–909, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Daosukho, Y. Chen, T. Noel et al., “Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury,” Free Radical Biology and Medicine, vol. 42, no. 12, pp. 1818–1825, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. T. Adachi, H. Yasuda, S. Nakamura et al., “Endoplasmic reticulum stress induces retinal endothelial permeability of extracellular-superoxide dismutase,” Free Radical Research, vol. 45, no. 9, pp. 1083–1092, 2011. View at Publisher · View at Google Scholar
  49. Z. F. Luo, B. Feng, J. Mu et al., “Effects of 4-phenylbutyric acid on the process and development of diabetic nephropathy induced in rats by streptozotocin: regulation of endoplasmic reticulum stress-oxidative activation,” Toxicology and Applied Pharmacology, vol. 246, no. 1-2, pp. 49–57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. E. Erbay, V. R. Babaev, J. R. Mayers et al., “Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis,” Nature Medicine, vol. 15, no. 12, pp. 1383–1391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. K. Tveten, Ø. L. Holla, T. Ranheim, K. E. Berge, T. P. Leren, and M. A. Kulseth, “4-Phenylbutyrate restores the functionality of a misfolded mutant low-density lipoprotein receptor,” FEBS Journal, vol. 274, no. 8, pp. 1881–1893, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Ono, M. Ikemoto, T. Kawarabayashi et al., “A chemical chaperone, sodium 4-phenylbutyric acid, attenuates the pathogenic potency in human α-synuclein A30P + A53T transgenic mice,” Parkinsonism and Related Disorders, vol. 15, no. 9, pp. 649–654, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Ricobaraza, M. Cuadrado-Tejedor, A. Pérez-Mediavilla, D. Frechilla, J. Del Río, and A. García-Osta, “Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an alzheimer's disease mouse model,” Neuropsychopharmacology, vol. 34, no. 7, pp. 1721–1732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. W. Qi, J. Mu, Z. F. Luo et al., “Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response,” Metabolism, vol. 60, no. 5, pp. 594–603, 2011. View at Publisher · View at Google Scholar · View at Scopus
  55. G. S. Zode, M. H. Kuehn, D. Y. Nishimura et al., “Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma,” Journal of Clinical Investigation, vol. 121, no. 9, pp. 3542–3553, 2011. View at Publisher · View at Google Scholar
  56. S. W. Brusilow and N. E. Maestri, “Urea cycle disorders: diagnosis, pathophysiology, and therapy,” Advances in pediatrics, vol. 43, pp. 127–170, 1996. View at Google Scholar · View at Scopus
  57. C. Xiao, A. Giacca, and G. F. Lewis, “Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and β-cell dysfunction in humans,” Diabetes, vol. 60, no. 3, pp. 918–924, 2011. View at Publisher · View at Google Scholar